Sanofi (SNYNF)
OTCMKTS
· Delayed Price · Currency is USD
107.60
0.00 (0.00%)
Oct 4, 2024, 4:00 PM EDT
Sanofi Revenue
Sanofi had revenue of 11.38B EUR in the quarter ending June 30, 2024, with 7.48% growth. This brings the company's revenue in the last twelve months to 47.08B, up 2.25% year-over-year. In the year 2023, Sanofi had annual revenue of 46.03B with 1.42% growth.
Revenue (ttm)
47.08B EUR
Revenue Growth
+2.25%
P/S Ratio
n/a
Revenue / Employee
546.88K EUR
Employees
86,088
Market Cap
137.91B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 46.03B | 644.00M | 1.42% |
Dec 31, 2022 | 45.39B | 6.21B | 15.86% |
Dec 31, 2021 | 39.18B | 1.81B | 4.83% |
Dec 31, 2020 | 37.37B | -262.00M | -0.70% |
Dec 31, 2019 | 37.63B | 1.95B | 5.48% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sandoz Group AG | 10.11B |
Telix Pharmaceuticals Limited | 430.80M |
Elekta AB (publ) | 1.69B |
Ryman Healthcare Limited | 411.39M |
Verano Holdings Corp. | 920.97M |
Medexus Pharmaceuticals Inc. | 108.78M |
Sanofi News
- 4 days ago - Sanofi consumer health unit bidders revising offers over talc powder concerns - report - Seeking Alpha
- 4 days ago - Sanofi Healthcare Bidders Revising Offers Over Talc Concerns - BNN Bloomberg
- 4 days ago - GSK, Sanofi, And CSL Secure US Government Fund To Boost Bird Flu Vaccine Production: Report - Benzinga
- 4 days ago - GSK, Sanofi, CSL said to win $72M U.S. bird flu vaccine contract - Seeking Alpha
- 4 days ago - Evaluating Eli Lilly Against Peers In Pharmaceuticals Industry - Benzinga
- 4 days ago - Sanofi Sells Global Rights To Rare Autoimmume Drug Enjaymo For $825M Upfront To Italian Firm Recordati - Benzinga
- 4 days ago - Sanofi, GSK, CSL tapped to expand US bird flu vaccine supply, Bloomberg News reports - Reuters
- 4 days ago - Sanofi inks $1B deal to sell autoimmune disorder therapy - Seeking Alpha